CClinicalTrials.gg
RecruitingNCT06194292TEVTMSUpdated Jan 8, 2024

Work in Green Spaces and Musculoskeletal Disorders

An observational study in Musculoskeletal Disorders, sponsored by University Hospital, Strasbourg, France. Recruiting at 1 site in France. Open to participants aged 18 Years to 62 Years. Per ClinicalTrials.gov, last updated 2024-01-08.

Sponsored by University Hospital, Strasbourg, France · Observational

From the registry’s dates

  • Primary completion was expected by Jun 2024, 2 years 4 months ago, but the record still lists the study as recruiting.
  • Started Jun 2023; still recruiting 3 years 3 months later.
Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
50
Ages
18 Years to 62 Years
Sex
All
01

Study summary

Musculoskeletal disorders (MSDs) of the limbs and spine are painful conditions of the periarticular soft tissues (muscles, tendons, vessels, etc.) and peripheral nerves secondary to overuse of occupational origin.

They can manifest as pain (the most common symptom), discomfort, stiffness, loss of precision in movements or loss of strength. The lumbar spine and upper limbs are the parts of the body most frequently affected by MSDs.

MSDs have a multifactorial origin that can be separated into 2 categories: factors linked to the individual (age, sex, medical history) and factors linked to the work environment (biomechanical constraints, work organization, psychosocial risks).

MSDs are the leading cause of compensated occupational illnesses in France (86% of occupational illnesses in 2021, according to the Health Insurance annual report), particularly in the agricultural sector to which the majority of professions in green spaces belong. . If, in the Grand Est of France, the prevalence of employees exposed to physical risks decreased in the majority of sectors of activity between 1994 and 2017, we note at the same time a slight increase in the prevalence in the agricultural sector over this period. same period (6% in 2017 compared to 3.7% in 1994, SUMER 2017 survey).

Concerning the current context in France, the green spaces sector has undergone changes in recent years following the national implementation of the Ecophyto plan in 2008 (updated in 2015 then in 2018). This plan, the latest version of which is called Ecophyto 2+, aims to reduce the use of plant protection products by 50% by 2025. At the same time, the use of plant protection products for the maintenance of green spaces, forests, roads and walks have been prohibited by the Labbé law since January 1, 2017. In this context, and given the absence of recent data from the literature on this subject in France, the investigator wishes to carry out an inventory recent physical and organizational constraints, as well as the prevalence of MSDs, in the green space sector (targeting more particularly in its study the green spaces of the Territorial Civil Service of the Grand Est)

02

Conditions studied

  • Musculoskeletal Disorders

Keywords

  • Musculoskeletal disorders
  • Osteoarticular
03

In context

Musculoskeletal Diseases

657 studies on the registry are indexed under Musculoskeletal Diseases; 159 are open to participants now.

This study's planned enrollment of 50 is below the median of 126 across 201 observational studies indexed under Musculoskeletal Diseases.

Browse Musculoskeletal Diseases studies →

Lead sponsor

University Hospital, Strasbourg, France is the lead sponsor of 966 studies on the registry; 342 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 62 Years
Sexes eligible
All
Sampling method
Non-probability sample

Study population

Major subject from 18 to 62 years old working in the service of green spaces in the Territorial Civil Service in a city in the Grand Est, active when the study was carried out

Inclusion criteria

  • Major subject from 18 to 62 years old
  • Subject working in the service of green spaces in the Territorial Civil Service in a city in the Grand Est, active when the study was carried out
  • Subject agreeing to participate in the study
  • Subject with sufficient command of the French language to understand the self-questionnaire

Exclusion criteria

Exclusion Criteria:

  • Subject not wishing to participate in the study
  • Subject on sick leave
  • Subject under 18 years old or over 62 years old
  • Subject under guardianship or curatorship
  • Subject under judicial protection
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
50 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Retrospective description of the working conditions of green space maintenance workers leading to musculoskeletal disorders

    Time frame: Through study completion, an average of 2 months

07

Study locations

1 of 1 sites recruiting
  • Service de Pathologie Professionnelle - Médecine de Travail - CHU de Strasbourg - France
    Strasbourg, 67091, France
    • Marc André GOLTZENE, MD · Contact · marcandre.goltzene@chru-strasbourg.fr · 33 3 88 11 64 66
    • Gauthier CASPAR, MD · Contact · gauthier.caspary@chru-strasbourg.fr · 33 3 88 11 64 66
    • Marc André GOLTZENE, MD · Principal investigator
    • Gauthier CASPAR, MD · Principal investigator
    • Myriam Tchagaspanian, MD · Sub investigator
    • Sébastien Pelletier, MD · Sub investigator
    • Daniel Beck, MD · Sub investigator
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 8, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06194292
Lead sponsor
University Hospital, Strasbourg, France
Responsible party
Sponsor
First posted
Jan 8, 2024
Start date
Jun 12, 2023
Primary completion
Jun 2024 (estimated)
Completion
Jun 2024 (estimated)
Last update
Jan 8, 2024

Study contacts

Marc André GOLTZENE, MD
Contact
marcandre.goltzene@chru-strasbourg.fr
33 3 88 11 64 66

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion